Journal Logo

Most Popular Articles

Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study

Kurosaki, Takashi; Mitani, Seiichiro; Tanaka, Kaoru; More

Anti-Cancer Drugs. 32(1):95-101, January 2021.

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

Inagaki, Chiaki; Shimoi, Tatsunori; Okuma, Hitomi; More

Anti-Cancer Drugs. 29(1):97-101, January 2018.

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes

Stathopoulos, George P.; Malamos, Nikolaos A.; Markopoulos, Christos; More

Anti-Cancer Drugs. 25(8):950-957, September 2014.

Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab

Marushima, Hideki; Kimura, Hiroyuki; Miyazawa, Tomoyuki; More

Anti-Cancer Drugs. 31(2):177-182, February 2020.

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Sanfilippo, Roberta; Dileo, Palma; Blay, Jean-Yves; More

Anti-Cancer Drugs. 26(6):678-681, July 2015.

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Bernier, Cynthia; Soliman, Ahmed; Gravel, Michel; More

Anti-Cancer Drugs. 29(8):774-785, September 2018.

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Leonard, Shannon C.; Lee, Helen; Gaddy, Daniel F.; More

Anti-Cancer Drugs. 28(10):1086-1096, November 2017.

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

Grenader, Tal; Pavel, Marianne E.; Ruszniewski, Philippe B.; More

Anti-Cancer Drugs. 31(3):216-222, March 2020.

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer

Koh, Yoko; Kawashima, Atsunari; Ujike, Takeshi; More

Anti-Cancer Drugs. 31(10):1099-1102, November 2020.

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

Durairaj, Chandrasekar; Ruiz-Garcia, Ana; Gauthier, Eric R.; More

Anti-Cancer Drugs. 29(3):271-280, March 2018.

Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy

Mitani, Akihisa; Jo, Taisuke; Yasunaga, Hideo; More

Anti-Cancer Drugs. 29(6):560-564, July 2018.

Modified Glasgow Prognostic Score predicts survival among advanced non-small cell lung carcinoma patients treated with anti-PD1 agents

Freitas, Cláudia; Jacob, Maria; Tavares, Nuno; More

Anti-Cancer Drugs. 32(6):567-574, June 2021.

Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer

Kim, Hyo Song; Yi, Seong Yoon; Jun, Hyun Jung; More

Anti-Cancer Drugs. 21(1):107-112, January 2010.

S-allylcysteine induces cytotoxic effects in two human lung cancer cell lines via induction of oxidative damage, downregulation of Nrf2 and NF-κB, and apoptosis

Orozco-Morales, Mario; Hernández-Pedro, Norma Yanet; Barrios-Bernal, Pedro; More

Anti-Cancer Drugs. 32(2):117-126, February 2021.

The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows

Di Vita, Maria; Cappellani, Alessandro; Piccolo, Gaetano; More

Anti-Cancer Drugs. 26(2):123-138, February 2015.

A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway

Zeng, Fanwei; Luo, Fanghong; Lv, Sha; More

Anti-Cancer Drugs. 25(6):663-672, July 2014.